COL18A1 and arthritic joint disease: A number of angiogenesis inhibitors are being studied; among these are endostatin, thalidomide, AE- 941(Neovastat), bevacizumab (also known as Avastin, anti-VEGF, RhuMabVEGF) and the arthritis medication celocoxib.